Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) EBT Margin (2019 - 2025)

Silo Pharma's EBT Margin history spans 7 years, with the latest figure at 6160.54% for Q3 2025.

  • For Q3 2025, EBT Margin fell 100762.0% year-over-year to 6160.54%; the TTM value through Sep 2025 reached 7041.12%, down 189031.0%, while the annual FY2024 figure was 6092.59%, 105655.0% down from the prior year.
  • EBT Margin for Q3 2025 was 6160.54% at Silo Pharma, up from 6681.24% in the prior quarter.
  • Across five years, EBT Margin topped out at 644539.63% in Q4 2021 and bottomed at 1344010.56% in Q3 2021.
  • The 5-year median for EBT Margin is 5312.14% (2022), against an average of 43351.13%.
  • The largest annual shift saw EBT Margin tumbled -134011866bps in 2021 before it surged 133855566bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 644539.63% in 2021, then crashed by -101bps to 9224.63% in 2022, then skyrocketed by 37bps to 5833.66% in 2023, then tumbled by -65bps to 9600.69% in 2024, then soared by 36bps to 6160.54% in 2025.
  • Per Business Quant, the three most recent readings for SILO's EBT Margin are 6160.54% (Q3 2025), 6681.24% (Q2 2025), and 5721.94% (Q1 2025).